Harrow, Inc. (HROW)
30.12
+1.82
(+6.43%)
USD |
NASDAQ |
Nov 13, 16:00
30.00
-0.12
(-0.40%)
Pre-Market: 08:35
Harrow Shareholders Equity (Quarterly) : 29.19M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 29.19M |
| June 30, 2026 | 15.20M |
| March 31, 2026 | 28.71M |
| December 31, 2025 | 52.45M |
| September 30, 2025 | 47.02M |
| June 30, 2025 | 49.65M |
| March 31, 2025 | 56.45M |
| December 31, 2024 | 69.65M |
| September 30, 2024 | 57.60M |
| June 30, 2024 | 58.08M |
| March 31, 2024 | 60.09M |
| December 31, 2023 | 70.36M |
| September 30, 2023 | 75.76M |
| June 30, 2023 | 22.41M |
| March 31, 2023 | 21.88M |
| December 31, 2022 | 27.60M |
| September 30, 2022 | 1.217M |
| June 30, 2022 | 5.749M |
| March 31, 2022 | 10.09M |
| December 31, 2021 | 11.29M |
| September 30, 2021 | 16.59M |
| June 30, 2021 | 23.20M |
| March 31, 2021 | 28.22M |
| December 31, 2020 | 27.18M |
| September 30, 2020 | 25.28M |
| Date | Value |
|---|---|
| June 30, 2020 | 15.73M |
| March 31, 2020 | 15.34M |
| December 31, 2019 | 27.71M |
| September 30, 2019 | 23.96M |
| June 30, 2019 | 35.06M |
| March 31, 2019 | 37.06M |
| December 31, 2018 | 24.75M |
| September 30, 2018 | 4.453M |
| June 30, 2018 | 3.732M |
| March 31, 2018 | 0.083M |
| December 31, 2017 | 2.615M |
| September 30, 2017 | 3.746M |
| June 30, 2017 | 7.646M |
| March 31, 2017 | 5.317M |
| December 31, 2016 | 6.432M |
| September 30, 2016 | 2.832M |
| June 30, 2016 | 5.608M |
| March 31, 2016 | 8.784M |
| December 31, 2015 | -1.385M |
| September 30, 2015 | 2.244M |
| June 30, 2015 | 5.24M |
| March 31, 2015 | 6.206M |
| December 31, 2014 | 8.150M |
| September 30, 2014 | 10.28M |
| June 30, 2014 | 12.04M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Viatris, Inc. | 13.69B |
| ANI Pharmaceuticals, Inc. | 637.11M |
| Corcept Therapeutics, Inc. | 833.74M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 81.53B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 443.02M |
| Total Liabilities (Quarterly) | 414.19M |
| Debt to Equity Ratio | 10.31 |
| Current Ratio | 2.288 |
| Net Debt Paydown Yield | -1.20% |